You are here

Home » CERID Bibliography

CERID Bibliography

Export 1663 results:
Author Title Type [ Year(Asc)]
2011
Ramabu SS, Schneider DA, Brayton KA, Ueti MW, Graça T, Futse JE, Noh SM, Baszler TV, Palmer GH. Expression of Anaplasma marginale ankyrin repeat-containing proteins during infection of the mammalian host and tick vector. Infect Immun. 2011 ;79(7):2847-55.
Hewitt SN, Choi R, Kelley A, Crowther GJ, Napuli AJ, Van Voorhis WC. Expression of proteins in Escherichia coli as fusions with maltose-binding protein to rescue non-expressed targets in a high-throughput protein-expression and purification pipeline. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 ;67(Pt 9):1006-9.
Tangen JM, Murphy SC, Thompson MB. Flashed face distortion effect: grotesque faces from relative spaces. Perception. 2011 ;40(5):628-30.
Begley DW, Davies DR, Hartley RC, Edwards TE, Staker BL, Van Voorhis WC, Myler PJ, Stewart LJ. Fragment screening of infectious disease targets in a structural genomics environment. Methods Enzymol. 2011 ;493:533-56.
Mesplet M, Palmer GH, Pedroni MJ, Echaide I, Florin-Christensen M, Schnittger L, Lau AOT. Genome-wide analysis of peptidase content and expression in a virulent and attenuated Babesia bovis strain pair. Mol Biochem Parasitol. 2011 ;179(2):111-3.
R de Claro A, Zhu X, Tang J, Morgan-Stevenson V, Schwartz BR, Iwata A, W Liles C, Raines EW, Harlan JM. Hematopoietic Fas deficiency does not affect experimental atherosclerotic lesion formation despite inducing a proatherogenic state. Am J Pathol. 2011 ;178(6):2931-7.
Bryan CM, Bhandari J, Napuli AJ, Leibly DJ, Choi R, Kelley A, Van Voorhis WC, Edwards TE, Stewart LJ. High-throughput protein production and purification at the Seattle Structural Genomics Center for Infectious Disease. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 ;67(Pt 9):1010-4.
Harman AN, Lai J, Turville S, Samarajiwa S, Gray L, Marsden V, Mercier SK, Mercier S, Jones K, Nasr N, et al. HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production. Blood. 2011 ;118(2):298-308.
Gottlieb GS, Smith RA, Badiane NMery Dia, Ba S, Hawes SE, Toure M, Starling AK, Traore F, Sall F, Cherne SL, et al. HIV-2 integrase variation in integrase inhibitor-naïve adults in Senegal, West Africa. PLoS One. 2011 ;6(7):e22204.
Johnston C, Koelle DM, Wald A. HSV-2: in pursuit of a vaccine. J Clin Invest. 2011 ;121(12):4600-9.
Agnes JT, Brayton KA, LaFollett M, Norimine J, Brown WC, Palmer GH. Identification of Anaplasma marginale outer membrane protein antigens conserved between A. marginale sensu stricto strains and the live A. marginale subsp. centrale vaccine. Infect Immun. 2011 ;79(3):1311-8.
Crowther GJ, Napuli AJ, Gilligan JH, Gagaring K, Borboa R, Francek C, Chen Z, Dagostino EF, Stockmyer JB, Wang Y, et al. Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds. Mol Biochem Parasitol. 2011 ;175(1):21-9.
Loo Y-M, Gale M. Immune signaling by RIG-I-like receptors. Immunity. 2011 ;34(5):680-92.
Darwish I, Mubareka S, W Liles C. Immunomodulatory therapy for severe influenza. Expert Rev Anti Infect Ther. 2011 ;9(7):807-22.
Higgins SJ, Kain KC, W Liles C. Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria. Expert Rev Anti Infect Ther. 2011 ;9(9):803-19.
Quakkelaar ED, Redeker A, Haddad EK, Harari A, McCaughey SM, Duhen T, Filali-Mouhim A, Goulet J-P, Loof NM, Ossendorp F, et al. Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors. PLoS One. 2011 ;6(2):e16819.
Hanson MP, Kwan-Gett TS, Baer A, Rietberg K, Ohrt M, Duchin JS. Infant pertussis epidemiology and implications for tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination: King County, Washington, 2002 through 2007. Arch Pediatr Adolesc Med. 2011 ;165(7):647-52.
Hawkes M, Opoka RO, Namasopo S, Miller C, Thorpe KE, Lavery JV, Conroy AL, W Liles C, John CC, Kain KC. Inhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial. Trials. 2011 ;12:176.
Serghides L, Kim H, Lu Z, Kain DC, Miller C, Francis RC, W Liles C, Zapol WM, Kain KC. Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria. PLoS One. 2011 ;6(11):e27714.
Perwitasari O, Cho H, Diamond MS, Gale M. Inhibitor of κB kinase epsilon (IKK(epsilon)), STAT1, and IFIT2 proteins define novel innate immune effector pathway against West Nile virus infection. J Biol Chem. 2011 ;286(52):44412-23.
Stroud C, Altevogt BM, Butler JC, Duchin JS. The Institute of Medicine's Forum on Medical and Public Health Preparedness for Catastrophic Events: regional workshop series on the 2009 H1N1 influenza vaccination campaign. Disaster Med Public Health Prep. 2011 ;5(1):81-6.
Nwaka S, Besson D, Ramirez B, Maes L, Matheeussen A, Bickle Q, Mansour NR, Yousif F, Townson S, Gokool S, et al. Integrated dataset of screening hits against multiple neglected disease pathogens. PLoS Negl Trop Dis. 2011 ;5(12):e1412.
Brien JD, Daffis S, Lazear HM, Cho H, Suthar MS, Gale M, Diamond MS. Interferon regulatory factor-1 (IRF-1) shapes both innate and CD8(+) T cell immune responses against West Nile virus infection. PLoS Pathog. 2011 ;7(9):e1002230.
Roberts MC, Soge OO, No D, Beck NK, Meschke JS. Isolation and characterization of methicillin-resistant Staphylococcus aureus from fire stations in two northwest fire districts. Am J Infect Control. 2011 ;39(5):382-9.
Gujjar R, El Mazouni F, White KL, White J, Creason S, Shackleford DM, Deng X, Charman WN, Bathurst I, Burrows J, et al. Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice. J Med Chem. 2011 ;54(11):3935-49.

Pages